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Abstract: HIV dynamical models are often based on non-linear sys-
tems of ordinary differential equations (ODE), which do not have analytical
solution. Introducing random effects in such models leads to very challeng-
ing non-linear mixed-effects models. To avoid the numerical computation
of multiple integrals involved in the likelihood, we propose a hierarchical
likelihood (h-likelihood) approach, treated in the spirit of a penalized like-
lihood. We give the asymptotic distribution of the maximum h-likelihood
estimators (MHLE) for fixed effects, a result that may be relevant in a more
general setting. The MHLE are slightly biased but the bias can be made
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negligible by using a parametric bootstrap procedure. We propose an effi-
cient algorithm for maximizing the h-likelihood. A simulation study, based
on a classical HIV dynamical model, confirms the good properties of the
MHLE. We apply it to the analysis of a clinical trial.
Keywords: algorithm, asymptotic, differential equations, h-likelihood,
HIV dynamics models, non-linear mixed effects model, penalized likelihood.
1 INTRODUCTION
Since the influential paper of Ho et al. (1995) there has been a strong
impetus to develop mathematical models for better understanding the in-
teraction between HIV and the immune system; see Nowak and May (2000).
However the statistical inference in these models has raised major challenges
coming from the intrication of identifiability and numerical problems. The
first problem is numerical: in general the trajectories of the interesting
quantities (e.g. viral load or CD4 counts) are solutions of non-linear differ-
ential equations that do not have analytical solutions. The second problem
is the identifiability problem: the observations recorded on one subject are
not informative enough to estimate all the parameters of the model. The
first problem is either avoided, simplifying the models to obtain analyti-
cal solutions (Wu and Ding, 1999), or solved by using numerical solvers of
ordinary differential equations (ODE); Ramsay et al. (2007) proposed an
original approach but did not apply it to a random effect model. The second
problem is partly treated by considering that the particular values of the pa-
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rameters for each subject are realizations of random variables with a given
distribution in the population. This puts the problem in the framework of
non-linear mixed effects models. Laplace approximation of the numerical
integrals involved in the computation of the likelihood has been proposed
(Beal and Sheiner, 1982; Lindstrom and Bates, 1990); adaptive Gaussian
quadrature is another possibility (see Davidian and Giltinan, 1995). We re-
fer to Wu (2005) for a review of statistical issues in HIV models. Recently a
stochastic approximation EM (SAEM) algorithm has been proposed (Kuhn
and Lavielle, 2005; Donnet and Samson, 2007). In the specific case of HIV
dynamics models a Bayesian approach has been proposed by Putter et al.
(2002) and Huang, Liu and Wu (2006), while a special algorithm for com-
puting the likelihood and maximizing using a Newton-like method has been
proposed by Guedj, Thie´baut and Commenges (2007). However all these
methods present difficulties and can be time-consuming.
The hierarchical likelihood (h-likelihood) has been proposed for general-
ized linear models with random effects by Lee and Nelder (1996) and further
studied in Lee and Nelder (2001) and Lee, Pawitan and Nelder (2006) and
for non-linear mixed effects models by Noh and Lee (2008). This is very
similar to an approach called penalized likelihood used by McGilChrist and
Aisbett (1991) and Therneau and Grambsch (2000) for frailty models. The
main idea is to treat the random effects (or the frailties) as parameters
and to find estimates of all the parameters by maximizing a function which
is essentially the loglikelihood conditional on the random effects minus a
penalty term which takes large values if the “random” parameters are very
dispersed. Penalized likelihood has also been used for function estimation
(O’Sullivan; 1988). The advantage of this approach is that it may avoid
computing numerical integrals. The curse of dimensionality is transferred
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from the dimension of numerical integrals to the dimension of the space on
which maximization takes place. There are problems with this approach.
One is the asymptotic distribution of the estimators of the fixed parame-
ters; another is the estimation of the variances of the random parameters.
Consistency of the maximum h-likelihood estimators (MHLE) has not been
proved. It is often suggested to revert to the likelihood to have consistent
estimators of the fixed parameters, but then the most important benefits
of h-likelihood in terms of computational burden is lost. Last but not least
is the problem of maximizing a complicated function over several hundred
parameters.
The aim of this paper is to develop a (partly non-standard) h-likelihood
approach to HIV dynamics models which completely avoids computation of
the likelihood. This is in the spirit of penalized likelihood in the sense that
we do not try to precisely estimate the variances of the random effects. One
aim is to study the asymptotic distribution of the MHLE for a given choice
of the penalty. Another aim is to find an efficient maximization algorithm.
The paper is organized as follows. In section 2 we describe a statistical
model based on an ODE system in a general form and in a particular form
which will be used for simulations. In section 3 we describe h-likelihood and
we give the asymptotic distribution of the MHLE for fixed effects when the
number of subjects tends toward infinity. We propose a parametric boot-
strap procedure to correct the bias of the MHLE. In section 4 we propose
a strategy for choosing the penalty based on the guess of an upper bound
of the variance of the random effects. An efficient maximization algorithm
is presented in section 5. Section 6 presents a simulation study. Section 7
presents the analysis of a clinical trial. We conclude in section 8.
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2 A POPULATION DYNAMICS MODEL
2.1 A general model for the system
The dynamics of the concentrations of virions and CD4+ T-cells (in short,
CD4) in different stages (represented by X i(t)) can be described by an
ODE system. We allow the values of the parameters to vary between sub-
jects; thus we consider a population model, as in Guedj, Thie´baut and
Commenges (2007). For subject i with i = 1, ...n, this can be written:
dX i(t)
dt
= f(X i(t), ξi)
X i(0) = h(ξi)
(1)
where X i(t) = (X i1(t), ..., X
i
K(t))
′ is the vector of the K state variables
(or components); ξi = (ξi1, ..., ξ
i
p) is a vector of p individual parameters
which appear naturally in the ODE system and have generally a biological
interpretation. Similarly to generalized (mixed) linear models, we introduce
a link function which relates ξi to a linear model involving explanatory
variables and random effects:
Ψl(ξ
i
l ) = ξ˜
i
l =
 φl + b
i
l + z
i
l (t)βl, l = 1, . . . , R,
φl + z
i
l (t)βl, l = R + 1, . . . , p,
(2)
where φl is the intercept, z
i
l (t) are vectors of explanatory variables associ-
ated with the fixed effects of the lth biological parameter; these explana-
tory variables may be time-dependent, in which case the ODE system has
time-dependent parameters. The βl’s are vectors of regression coefficients;
bi = (b
i
1, . . . , b
i
R) is the individual vector of random effects. We assume
bi ∼ N (0,Σ) with Σ diagonal with diagonal elements τ 2l . More general
models could of course be considered.
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2.2 Model for the observations
Let Yijm denote the jth measurement of the mth observable component for
subject i at time tijm; we assume that:
Yijm = gm(X
i(tijm)) + ijm, i = 1, ..., n, j = 1, ..., nim, (3)
for m = 1, ...,M , where gm(.) are known functions and where the ijm
are independent Gaussian variables with zero mean and variances σ2m. The
ijm’s are supposed independent because they represent measurement errors.
The model for the observations may be complicated by the detection limits
of assays leading to left-censored observations Yijm.
2.3 A particular model for HIV dynamics
For illustrating the proposed method we present a version of a rather stan-
dard model for the HIV dynamics model, close to that used by Nowak and
Bangham (1996):
dT i
dt
= λi − γiT iV i − µiTT i
dT ∗i
dt
= γiT iV i − µiT ∗T ∗i
dV i
dt
= piiT ∗i − µiV V i
where T i, T ∗i represent the concentrations (implicitly depending on t) of
non-infected and infected CD4 respectively, and V i stands for the concen-
tration of virus.
Here the components of ξil = (λ
i, γi, µiT , µ
i
T ∗ , pi
i, µiV ) represent rates of
events such as production of new cells or particles, rates of infection after
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meeting between different particles. As for the Ψl(.), we will take the nat-
ural log-transform for all the parameters: the natural log-transform can be
justified if we think of the parameters as expectations of Poisson variables
and has the advantage that the standard deviations of the transformed pa-
rameters may be interpreted as coefficients of variations of the estimators
of the natural parameters. For the simulations, in the link equation (2) we
will take random effects for λi, pii and µiT ∗ (so R = 3) with the b
i
l being
normal and independent with variances τ 2λ , τ
2
pi , τ
2
µT∗ , respectively. For all
parameters except for γi we will take no explanatory variable. The effect of
the treatment will be modeled as modifying γi according to the equation:
γ˜i = log γi = γ0 + β1z
i
1(t) + β2z
i
2(t),
where zi1(t) and z
i
2(t) are treatment indicators. The treatment may change
with time; here we will suppose that they are fixed for t ≥ 0 but take
the value 0 for t < 0. We assume that at t = 0 the patients are at the
equilibrium of the system with zi1(t) = z
i
2(t) = 0 and this gives impor-
tant information. As for the observation equation (3) we will take in the
simulations:
Yij1 = log10 V
i(tij1) + ij1
Yij2 = [T
i(tij2) + T
∗i(tij2)]1/4 + ij2
Yij3 = [T
∗i(tij3)]1/4 + ij3
7
3 THE HIERARCHICAL OR PENALIZED
LIKELIHOOD
3.1 Asymptotic Distribution of the MHLE
Let us consider the following model: conditionally on bi, Yi has a density
fY (.; θ, bi), where θ is a vector of fixed parameters of dimension q (θ ∈ Θ ⊂
<q) and bi are random effects (or parameters) of dimension R. The (Yi, bi)
are independently identically distributed (iid). Typically Yi is multivariate
of dimension ni. We assume that the bi have density fb(.; τ ) with zero
expectation and where τ is a vector of parameters. We denote by P ∗ the
true probability and θ∗ and τ ∗ the parameter values which specify the
distribution of the observed Yi. Typically Yi is (at least partially) observed
while bi is not.
Estimators of both θ and b = (b1, . . . , bn) are defined as maximizing
the (normalized) extended loglikelihood, called here (by abuse of language)
h-loglikelihood:
HL(θ, b, τ ) = Lθ,b
n
− 1
n
n∑
i=1
J(bi; τ ),
where Lθ,bn is the loglikelihood (normalized by
1
n
) for the observation con-
ditional on b, and J(bi; τ ) = − log fb(bi; τ ). We denote by (θˆτ , bˆτ ) the
values which maximize HL(θ, b, τ ) for given τ ; θˆτ will be called the MHLE
of the parameters θ. We have HL(θ, b, τ ) = 1
n
∑n
i=1 hl(Yi; θ, bi, τ ) with
hl(Yi; θ, bi, τ ) = l(Yi; θ, bi) − J(bi; τ ), where l(Yi; θ, bi) is the loglikelihood
for subject i conditional on bi. For simpler notation we will not always
make the dependence in τ explicit and will write for instance HL(θ, b) for
HL(θ, b, τ ). We shall make the additional assumptions:
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A1 l(y; θ, bi) and J(bi; τ ) are continuous and twice-continuously differ-
entiable functions of θ and bi for all y and τ ;
A2 EP ∗l(Yi; θ, bi) exists for all θ ∈ Θ.
We shall derive asymptotic results for the MHLE of the fixed parameters
θ, which do not require that τ = τ ∗.
Lemma 1 Under assumptions A1 and A2 the MHLE for fixed effects are
M-estimators.
Proof. Consider the profile h-loglikelihood PHLn(θ) = HL(θ, bˆ(θ)), where
bˆ(θ) = argmaxb HL(θ, b). (θˆ
τ , bˆ(θˆτ )) maximizes PHLn(θ), thus θˆ
τ is the
profile h-likelihood estimator. Remembering that HL(θ, b) = 1
n
∑n
i=1 hl(Yi; θ, bi),
it is clear that the components of bˆ(θ) are the bˆi(θ) = argmaxbi [hl(Yi; θ, bi)].
Thus PHLn(θ) = HL(θ, bˆ(θ)) =
1
n
∑n
i=1 hl(Yi; θ, bˆi(θ)). It follows that θˆ
τ
is a M-estimator because it is clear that θˆτ is the maximum of Mn(θ) =
n−1
∑n
i=1mθ(Yi), wheremθ(y) is a known measurable function: heremθ(y) =
hl(y; θ, b(y; θ)) where b(y; θ) = argmaxb[hl(y; θ, b)] (Van der Vaart, 1998, p
41).
For the convergence result we need the additional assumption:
A3 For every sufficiently small ball U ∈ Θ, EP ∗ supθ∈U hl(y; θ, b(y; θ)) <∞.
In the convergence theorems of the MHLE we will emphasize the fact
that it depends on n by writing θˆτ = θˆτn .
Theorem 1 If Θ is compact and assumption A1-A3 holds, the MHLE of
fixed effects θˆτn converges in probability toward θ
τ
0 = argmaxθ EP ∗ [hl(Yi; θ, bˆi(θ))],
for any τ .
Proof. By the law of large numbers Mn(θ) →p M(θ) where M(θ) =
EP ∗ [hl(Yi; θ, bˆi(θ))]. Let us call θ
τ
0 the value, that we assume unique, at
9
which M(θ) attains its maximum. The conditions stated in the Theorem,
together with the continuity assumption A1, allow us to apply Wald’s con-
sistency proof (van der Vaart, 1998, Theorem 5.14, p48).
Corollary 1 The MHLE of the fixed parameter of the statistical model de-
scribed in section 2 converges in probability toward θτ0 = argmaxθ EP ∗ [hl(Yi; θ, bˆi(θ))].
Proof. In the case of the statistical model of section 2 we have hl(Yi; θ, bˆi(θ)) =∑M
m=1[−ni2 log σ2m−
∑ni
j=1
(Yijm−φm(tijm;θ,bˆi(θ)))2
2σ2m
]−∑Rr=1 bˆir(θ)22τ2 , where φm(tijm; θ, bi) =
gm(X
i(tijm)) (where X
i(tijm) is the solution of the ODE system with pa-
rameters θ, bi). In case where σ
2
m are fixed, assumption A3 is trivially
satisfied because we can remove the terms involving σ2m and obtain a func-
tion which is bounded by zero. If we include the σ2m in the parameters
that we wish to estimate, assumption A3 is satisfied since hl(Yi; θ, bˆi(θ)) ≤∑M
m=1−ni2 log σ2m −
∑ni
j=1
(Yijm−φm(tijm;θ,bˆi(θ)))2
2σ2m
≤ ∑Mm=1−ni2 log σ˜2m − ni/2,
with σ˜2m =
∑ni
j=1
(Yijm−φm(tijm;θ,bˆi(θ)))2
ni
. It seems reasonable to conjecture that
EP ∗ [− log (Yijm − φm(tijm; θ, bˆi(θ)))2] < ∞. We can compactify the space
by taking Θ = <¯d. If some parameters take an infinite value, hl(Yi; θ, bˆi(θ))
take either the value −∞ or a finite value.
Now the problem is to investigate whether θτ0 is equal or close to θ
∗.
M(θ) can be considered as an approximation of minus the Kullback-Leibler
divergence. This is obtained by replacing the expectation in b by the mode.
The approximation is exact if φm are linear functions in b but this is not
true in general. However there is a possibility of reducing the bias (see
section 3.3).
The asymptotic normal distribution holds for M-estimators under some
regularity conditions. We make use of Theorem 5.23 of van der Vaart (1998)
which only requires a Lipshitz condition on mθ(y) = hl(y; θ, b(y; θ)) that we
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can establish if the following assumption bearing on uθ(y) = ∂hl(y;θ,bˆ(y;θ))
∂θ
holds. We shall use uθi = u
θ(Yi) and will give an alternative expression in
formula (6).
A4 There is a neighborhood Θ0 ⊂ Θ of θτ0 such that the function m˙(y) =
supθ∈Θ0 u
θ(y) has the property: EP ∗‖m˙(Yi)‖2 <∞.
Theorem 2 Assume assumptions A1-A4 hold. Then
√
n(θˆτn −θτ0 ) is asymp-
totically normal with zero expectation and variance equal to
Σ(θτ0 ) = {EP ∗ [Hθ
τ
0
i ]}−1{EP ∗ [uθ
τ
0
i u
θτ0 T
i ]}{EP ∗ [Hθ
τ
0
i ]}−1,
where Hθi =
∂uθi
∂θ
.
Proof. The theorem follows by applying Theorem 5.23 of van der Vaart
(1998). In this theorem, the main condition is that there exists a measurable
function m˙ with EP ∗m˙
2 <∞ such that for every θ1 and θ2 in a neighborhood
Θ0 of θ0 we have:
|mθ1(y)−mθ2(y)| ≤ m˙(y)‖θ1 − θ2‖. (4)
A Taylor series expansion gives: mθ1 −mθ2 = (θ1 − θ2)T ∂mθ∂θ (θ˜), where
θ˜ ∈ Θ0. This yields:
|mθ1 −mθ2| ≤ ‖
∂mθ
∂θ
(θ˜)‖‖θ1 − θ2‖ ≤ sup
θ∈Θ0
‖∂mθ
∂θ
(θ)‖‖θ1 − θ2‖.
Then assumption A4 allows us applying the Theorem 5.23 of van der Vaart
(1998).
For applying Theorem 2, it remains to compute the first and second
derivatives of mθ(Yi) in terms of derivatives of the likelihood conditional
on the random effects. We write li(θ, bˆi(θ)) = l(Yi; θ, bˆi(θ)). Let us call
∂l
∂x
(resp. ∂l
∂z
) the derivatives of li(., .) wrt the first (resp. the second) argument
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and ∂J
∂z
the derivative of J(.) wrt its argument. We have uθi =
∂li
∂x
|θ,bˆi(θ) +
∂li
∂z
|θ,bˆi(θ) ∂bˆi∂θ |θ− ∂J∂z |bˆi(θ). However, because bˆi(θ) maximizes hl(Yi; θ, b) we have
∂li
∂z
|θ,bˆi(θ)
∂bˆi
∂θ
|θ − ∂J
∂z
|bˆi(θ) = 0. (5)
Hence we obtain that
uθi =
∂li
∂x
|θ,bˆi(θ). (6)
That is uθi is simply the derivative of the loglikelihood as if b was fixed,
computed in (θ, bˆi(θ)).
Next we have Hθi =
∂uθi
∂θ
= ∂
2li
∂x2
|θ,bˆi(θ) + ∂
2li
∂z∂x
|θ,bˆi(θ) ∂bˆi∂θ |θ. Differentiating
equation (5) wrt θ we have:
∂2li
∂x∂z
|θ,bˆi(θ) +
∂2li
∂z2
|θ,bˆi(θ)
∂bˆi
∂θ
|θ − ∂
2J
∂z2
|bˆi(θ)
∂bˆi
∂θ
|θ = 0,
from which we obtain:
∂bˆi
∂θ
|θ = −
[
∂2li
∂z2
|θ,bˆi(θ) −
∂2J
∂z2
|bˆi(θ)
]−1
∂2li
∂x∂z
|θ,bˆi(θ).
Hence:
Hθi =
∂2li
∂x2
|θ,bˆi(θ) −
∂2li
∂z∂x
|θ,bˆi(θ)
[
∂2li
∂z2
|θ,bˆi(θ) −
∂2J
∂z2
|bˆi(θ)
]−1
∂2li
∂x∂z
|θ,bˆi(θ).
In practice we can plug in the estimator θˆτ to obtain an estimator of
Σ(θτ0 ) (using the continuous mapping theorem). We may also use the ob-
served scores and Hessian. By virtue of the law of large numbers they
converge toward their expectations, and again the continuous mapping the-
orem allows to prove consistency of the resulting estimator.
3.2 Correction of the bias
We have shown in section 3.2 that the MHLE θˆτ tends toward θτ0 which
is in general different from θ∗; thus there is an asymptotic bias θτ0 − θ∗.
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Note that the asymptotic distribution is valid for any τ , and on the other
hand, θˆτ is biased even for τ = τ ∗. Thus the problem of this approach
is essentially that of the bias, although a small bias may be acceptable if
it goes with a small variance. We propose to partially correct the bias by
parametric bootstrap (Efron and Tibshirani, 1993).
Specifically, for s = 1, . . . , S, generate the bsi from fb(., τ ); generate Y
s
i
from fY (.; θˆ
τ , bsi ); compute the MHLE θˆ
τ ,s for these data. An estimator
of the bias is S−1
∑S
s=1(θˆ
τ ,s − θˆτ ). Thus the corrected estimator, called
cMHLE, is
θˇτ = θˆτ − S−1
S∑
s=1
(θˆτ ,s − θˆτ ).
This correction slightly increases the variance. The variance of θˇτ can be
computed through the formula var EP ∗(θˇ
τ |θˆτ )+EP ∗var(θˇτ |θˆτ ). Neglecting
the bias of the MHLE in this computation we obtain:
var θˇτ ≈ (1 + S−1)var θˆτ
4 PENALTY CHOICE
Profile likelihood has been proposed by Therneau and Grambsch (2000) and
Lee and Nelder (2001) but it has the drawback of requiring the computation
of the marginal likelihood. We propose a strategy for penalty choice which
avoids this computation. For any choice of τ = (τ1, . . . , τR) we have that
θˆτ has an asymptotic normal distribution with expectation θτ0 and with
a variance that can be estimated. We propose to take a reasonable upper
bound of τ , that is, the value τ u = (τu, . . . , τu) where τu is considered
as an approximate upper bound for the τ ∗i . First, note that since we are
working with natural logarithms of the biological parameters, the τi may
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be interpreted as coefficients of variation of these parameters. It seems
reasonable (and is in agreement with the literature) to expect coefficients
of variations of parameters such as rate of production of new lymphocytes
(λ) or death rate of uninfected lymphocytes (µT ) are not very large, that
is no more than 0.3.
5 MAXIMIZATION ALGORITHM
Newton-like algorithms use an approximation of the Hessian of the function
to maximize. Since there are many parameters, this matrix can be very
large. For instance in our application q = 7, R = 3, n = 100, so the number
of parameters is q + nR = 307. In complex problems, both gradient and
Hessian have to be computed numerically. Particular care must be spent
to compute the Hessian both economically and precisely. The algorithm we
propose is an adaptation of the Marquardt algorithm (Marquardt, 1963),
taking advantage of the special structure of the Hessian in our problem. We
draw two consequences of this special structure: (i) there are many terms
which are equal to zero, so we do not need to compute them; (ii) the matrix
is not far from being block-diagonal.
We shall first consider the particular case where the number of ran-
dom and fixed effects are equal (R = q) and the loglikelihood of subject
i, l(Yi; θ, bi), depends only on θ + bi. We are interested in maximizing the
following function:
HL(θ, b) =
1
n
n∑
i=1
l(Yi; θ, bi)− R∑
r=1
bir
2
2τ 2
 ·
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It is useful to reparametrize in term of ai = θ + bi. One finds
HL =
1
n
n∑
i=1
laii − R∑
r=1
(air − θr)2
2τ 2
 = 1
n
n∑
i=1
hli·
With this parameterization the loglikelihood, laii = l(Yi; θ, ai − θ), which
is the complex part, depends only on ai so that many derivatives of the
h-loglikelihood are very simple:
∂HL
∂θr
=
1
n
n∑
i=1
air − θr
τ 2
; (7)
∂2HL
∂θr∂air′
=
δrr′
nτ 2
;
∂2HL
∂air∂a
i′
r′
= 0, if i 6= i′ ; ∂
2HL
∂θr∂θr′
= −δrr′
τ 2
,
where δrr′ = 1 if and only if r = r
′. This leads to a specific block structure
of the Hessian matrix, involving blocks A = ∂
2HL
∂θ2
= − 1
τ2
IR and D =
∂2HL
∂θ∂ai
=
1
nτ2
IR (where IR is the identity matrix of dimension R; D does not depend
on i) and Ci =
1
n
∂2hli
∂a2i
; the structure is displayed in Figure 1.
Figure 1: Hessian matrix in the case R = q. A = − 1
τ 2
IR and D =
1
nτ 2
IR,
IR is the identity matrix of dimension R, and Ci =
1
n
∂2hli
∂a2i
.
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Fast computation of this large (n + 1)R × (n + 1)R Hessian matrix is
possible for two reasons: (i) only the terms of blocks Ci require computation
of the likelihood; (ii) for computing the terms of block Ci we only need to
compute the second derivatives of laii (and not of the whole h-likelihood).
Finally there are nR(R + 1)/2 terms to compute, each involving only one
computation of the solution of the ODE system (needed for the numerical
differentiation): it follows that the number of computations of the solution
of ODE system does not exceed that required for the computation of the
Hessian for an ordinary (without random effect) non-linear model with q
parameters !
The nearly diagonal structure of the Hessian led us to design the so-
called “patient-by-patient” algorithm, decoupling the optimization between
patients. Denoting by ai(k) and θ(k) the values at iteration k, iteration k+1
proceeds in two steps:
Step 1: For i = 1, . . . , n: make one Marquardt step for optimizing the
function laii −
∑R
r=1
(air−θr(k))2
2τ2
on ai; this gives ai(k + 1); Step 2: compute
θr(k + 1) =
1
n
∑n
i=1 a
i
r(k + 1) (which satisfies (7)); go to step 1 (until con-
vergence is reached).
The patient-by-patient algorithm works very well far from the maximum
when the global Marquardt algorithm is hampered by the need of a large
increase of the diagonal of the Hessian. However the decoupling between
patients also leads to a loss of efficiency so that close to the maximum
it is less efficient than the global Marquardt algorithm. This observation
led us to devise a hybrid algorithm: use the patient-by-patient algorithm
until all blocks Ci are definite-positive; then switch to the global Marquardt
algorithm. Note that ensuring that all blocks Ci be definite-positive does
not imply that the Hessian is so; generally however it is not far from being
16
the case so that the Marquardt algorithm is efficient.
We now consider the case where there are R fixed parameters, that we
call α, associated with a random effect; such as above the loglikelihood of
subject i, l(Yi; θ, bi), depends only on α+bi and a vector of fixed parameters
β. As in the preceding case, the Hessian has a particular structure (see
Figure 2). It involves the blocks A, D and Ci as above, and in addition
blocks B = ∂
2HL
∂β2
and Bi =
1
n
∂2hli
∂β∂ai
.
Figure 2: Hessian matrix in fixed and random effects case where A =
− 1
τ 2
IR, D =
1
nτ 2
IR (where IR is the identity matrix of dimension R),
B = ∂
2HL
∂β2
, Bi =
1
n
∂2hli
∂β∂ai
and Ci =
1
n
∂2hli
∂a2i
The idea, like previously, is to deal with the case where there are non-
definite positive Ci. For that, we use the two steps of the patient-by-patient
approach which give the individual parameters ai(k + 1) and their means
α(k+1). Then keeping these values fixed, we find the other fixed parameters
β(k + 1) by a step of Marquardt algorithm with the block B. As soon as
all blocks Ci and the block B are definite positive, we switch to the global
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Marquardt algorithm.
6 A SIMULATION STUDY
6.1 Description of the simulation study
We did simulations from the model described in section 2.3. We fixed (that
is we did not estimate) the parameters µ˜V , µ˜T and σi, at values which
are plausible in view of the literature (taking as time unit the day and
as volume unit the micro-liter): µ˜V = 3.40; µ˜T = −2.20; σi = 0.5, i =
1, 2, 3. The values for the other parameters (to be estimated), including
the two treatment effects β1 and β2, are given in Table 2. For each replica,
observations for n = 100 subjects were generated; for each subject nim = 10
observations for the three compartments (m = 1, 2, 3) were generated at
times 0, 3, 6, 9, 12, 15, 18, 21, 24, 30.
6.2 Efficiency of the algorithm
We did a simulation to compare the number of iterations of the global Mar-
quardt algorithm and the hybrid algorithm. We tried the two algorithms
with models including one to three random effects. The initial values were:
λ˜ = 5.0; µ˜T ∗ = 0; p˜i = 0; γ˜0 = −5.0; β1 = −1.0; β2 = −1.0. The global
Marquardt algorithm did not always converge in less than 150 iterations
while the hybrid algorithm nearly always converged (see Table 1); when
they both converged, this was toward the same values (close to the true
parameter values). We checked that when we started from different values
the algorithms converged toward the same values. The hybrid algorithm is
faster than the global one. In Table 1 we give the mean number of iterations
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Table 1: Percentage of convergence in less than 150 iterations and mean
number of iterations to converge with different random effects for the Global
Marquardt and Hybrid algorithm.
Random effects
Global algorithm Hybrid algorithm
nb iter % success nb iter % success
λ˜ 35 81% 11 100%
λ˜, µ˜T ∗ 54 59% 17 100%
λ˜, µ˜T ∗ , p˜i 71 49% 25 94%
until convergence (computed on 100 replications) for which the algorithm
converged in less than 150 iterations. For instance the mean number of
iterations for 3 random effects was 25 versus 71 for the hybrid versus the
global algorithm. The mean time of one iteration is about the same for the
two algorithms. To give an idea in terms of computation time, the hybrid
algorithm took about 10 mn for the case with three random effects on a
standard work station (Bi Xeon, 3.8 GHz).
6.3 Efficiency of the bias correction
We estimated the bias of the corrected θˇτ and uncorrected MHLE θˆτ using
500 replicas of a distribution with three random effects bearing on λ˜, µ˜T ∗ , p˜i.
We first examine the case where τ = τ ∗ = (0.2, 0.2, 0.2). The biases of the
uncorrected MHLE are of order 10−2 for all parameters. The correction
reduces the biases to the order of 10−3 (except for one parameter), which
seems negligible.
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Table 2: Parameter values for the simulation and uncorrected and corrected
biases
Parameters True value Mean estimated value Bias
non corr corr non corr corr
λ˜ 4.10 4.14 4.10 4.03 10−2 1.67 10−3
µ˜T ∗ −1.60 −1.54 −1.60 5.57 10−2 3.67 10−3
p˜i −0.170 −0.160 −0.166 1.01 10−2 3.69 10−3
γ0 −3.00 −2.98 −3.00 1.50 10−2 −3.60 10−3
β1 −1.10 −1.08 −1.10 2.04 10−2 2.59 10−3
β2 −1.40 −1.35 −1.39 4.55 10−2 1.11 10−2
6.4 Property of the cMHLE
We wished to check whether the asymptotic results hold in practice. We
simulated data from the standard model of section 2.3. In the first simu-
lation (case 1) we took as standard deviations of the random effects τ ∗λ =
τ ∗µT = τ
∗
µT∗ = 0.2. In a second simulation (case 2) we took τ
∗
λ = 0.1,
τ ∗µT = 0.2, τ
∗
µT∗ = 0.3. We did 500 replications and computed the root
mean square errors (RMSE) and coverage rate of .95 confidence intervals
of the estimated fixed parameters obtained in fixing the components of τ u
in the h-likelihood at values τu = 0.1; 0.2; 0.3. The results for the RMSE
are shown in Table 3. In the first case, the results tend to be better when
τu = 0.2 which is closer to the τ ∗r , while τ
u = 0.3 tends to be better than
τu = 0.1. For the second case the results for τu = 0.2 and τu = 0.3 were
approximately of the same quality, better than for τu = 0.1. It is striking
20
that most of the RMSE are roughly of the same order, between 10−2 and
10−1. These RMSE can be interpreted as typical relative errors on the nat-
ural parameter; in these simulation the order of magnitude is about 5%.
In term of coverage rates, the results (see Table 4) are not very good for
τu = 0.1. They are satisfactory for τu = 0.2 , and even more satisfactory
for τu = 0.3. This corroborates our strategy based on a reasonable upper
bound τu of the τ ∗r .
Table 3: Root Mean Square Error, 100 subjects, 500 replications.
τu 0.1 0.2 0.3
Par. case 1 case 2 case 1 case 2 case 1 case 2
λ˜ 5.62 10−2 4.47 10−2 3.34 10−2 3.94 10−2 4.95 10−2 3.76 10−2
µ˜T ∗ 9.10 10
−2 7.67 10−2 4.64 10−2 6.84 10−2 8.50 10−2 7.47 10−2
p˜i 7.27 10−2 5.95 10−2 5.14 10−2 5.86 10−2 5.25 10−2 5.71 10−2
γ0 2.60 10
−1 1.88 10−1 1.35 10−2 1.56 10−1 1.77 10−1 1.52 10−1
β1 1.74 10
−1 1.59 10−1 1.01 10−1 1.04 10−1 1.04 10−1 9.89 10−2
β2 1.67 10
−1 1.91 10−1 1.02 10−1 1.35 10−1 1.06 10−1 9.90 10−2
21
Table 4: Coverage rate, 100 subjects, 500 replications.
τu 0.1 0.2 0.3
Par. case 1 case 2 case 1 case 2 case 1 case 2
λ˜ 90% 81% 95% 92% 89% 89%
µ˜T ∗ 94% 81% 94% 88% 93% 89%
p˜i 96% 95% 94% 92% 93% 94%
γ0 97% 97% 98% 96% 94% 95%
β1 94% 87% 97% 93% 93% 94%
β2 85% 74% 97% 93% 92% 93%
7 APPLICATION TO A CLINICAL TRIAL
As an application of the proposed method, we aimed at estimating the
difference of treatment effects in a randomized clinical trial (Molina et al.,
1999). The ALBI ANRS 070 trial compared over 24 weeks the combination
of zidovudine plus lamivudine (AZT+3TC) with that of stavudine plus
didanosine (ddI+d4T) (a third arm alternating from one regimen to another
was not considered in this paper). The inclusion criteria were CD4 ≥ 200
cells/µL and HIV RNA level between 4 and 5 log10 copies/mL within 15
days before entry into the study. The primary outcome measure defined in
the study protocol was the antiretroviral effect as measured by the mean
change in HIV RNA level between baseline and 24 weeks by use of the
ultra-sensitive PCR assay with lower limit of quantification of 50 copies/mL
(1.7 log10). In the main analysis of Molina et al. (1999), HIV RNA values
reported as < 50 copies/mL were considered equivalent to 50 copies/mL; 51
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patients were included in each treatment group. Over the 24-week period,
HIV RNA level declined in the two groups, with mean (SE) decreases at
the end of the study of 1.26 (0.09) log10 copies/mL in the AZT+3TC group
and 2.26 (0.11) log10 copies/mL in the ddI+d4T group.
We used the model described in section 2.3. In this application only
the first two components Yij1 and Yij2 were observed. Moreover only a
left-censored version of Yij1 was observed; this was taken into account in
the likelihood as in Guedj, Thie´baut and Commenges (2007). In view of
less informative observations than in the simulations we fixed the values of
three parameters: µ˜T = −2.20, µ˜V = 3.40 and γ0 = −3. We put random
effects on λ, pi and µ∗T , working with τ
u = 0.3. The estimated values of the
parameters in natural logarithmic scale are displayed in Table 5. Reverting
to natural parameters we find: λˆ = 56.8 [54.1; 59.7]; pˆi = 0.79 [0.67; 0.92];
µˆT ∗ = 0.18 [0.17; 0.19]. In addition it was possible to test whether the two
treatment groups differed. The relevant null hypothesis is “η = 0”, where
η = β2 − β1. A natural test statistic is W = ηˆ√
v̂ar ηˆ
, where ηˆ = βˆ2 − βˆ1 and
v̂ar ηˆ can easily be computed from the estimate of the asymptotic variance
matrix Σ.
We found ηˆ = 0.242, v̂ar ηˆ = 5.16 10−3; this gives W = 3.37 and a
p-value equal to p = 7 10−4. Thus we conclude as expected that the treat-
ment groups differ, and more precisely that the infectivity of the virus has
been reduced more drastically in the ddI+d4T than in AZT+3TC group.
Baseline infectivity is multiplied by a factor estimated to eβˆ2 = 0.25 and
eβˆ1 = 0.32 in the ddI+d4T than in AZT+3TC groups respectively.
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Table 5: Estimated parameters based on the ALBI clinical trial
Parameters Uncorrected Values Corrected Values Confidence interval
λ˜ 4.05 4.04 [3.99; 4.09]
p˜i −0.129 −0.242 [−0.401;−0.083]
µ˜T ∗ −1.74 −1.73 [−1.80;−1.65]
β1 −1.33 −1.12 [−1.29;−0.957]
β2 −1.53 −1.37 [−1.56;−1.17]
σCD4 0.173 0.168 [0.151; 0.185]
σCV 0.584 0.541 [0.501; 0.582]
8 CONCLUSION
We have developed a hierarchical likelihood approach for inference in an
HIV dynamical model. We have obtained the asymptotic distribution of the
MHLE, we have derived a procedure which makes the bias negligible and
we have developed an efficient maximization algorithm. Our simulations
show that the whole approach works.
We have shown that it could be applied to the analysis of a real data
set. Rather precise estimates of the parameters were obtained. One limi-
tation of this approach is that some parameters must be fixed because of
identifiability problems. The model itself, although it is already statisti-
cally challenging, may be too simple from a biological point of view. The
development of such an approach would require richer data, for instance
observing the number of infected T cells.
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The main advantage of this approach is that it is easy to implement and
very fast as compared to the two main competing approaches, likelihood
and Bayesian inference. The main limitation is that it does not attempt to
estimate the variances of the random effects. In our application we already
have a knowledge of the range of values of these variances. Thus the method
can be used for exploring possible models while likelihood or Bayesian in-
ference can be used when estimates of the variances of the random effects
are needed.
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